SEAN BURRESS: Open Payments
NPI 1518693076 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,977 in 81 payments from 18 companies in 2025. Trend: 2023 $230 · 2024 $1,402 · 2025 $1,977
Food & beverage: $1,686Education: $291
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 13 | $291 |
| Otsuka America Pharmaceutical, Inc. | 9 | $290 |
| Novo Nordisk Inc | 9 | $255 |
| Ardelyx, Inc. | 8 | $210 |
| Mallinckrodt Hospital Products Inc. | 8 | $203 |
| Travere Therapeutics, Inc. | 8 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| Amgen Inc. | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $64 |
Products named: RAYALDEE, Ozempic, IBSRELA, ACTHAR, JYNARQUE, FARXIGA, Kerendia, KRYSTEXXA.
Industry payments across IL — which companies pay providers there.
